Octagam (Human Normal Immunoglobulin)

Human Normal Immunoglobulin, the active ingredient in Octagam, is an immunoglobulin presented as a sterile solution for intravenous use. It is used to replace missing antibodies and to modulate immune responses in patients with immune deficiencies and certain autoimmune conditions. GNH USA supplies Octagam as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

GNH USA supplies Octagam as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

Octagam is an immunoglobulin therapy that acts on the humoral immune system to provide passive immunity and immune modulation.

- Primary immunodeficiency diseases: helps restore adequate antibody levels and reduces infection frequency. - Chronic inflammatory demyelinating polyneuropathy (CIDP): decreases disease activity and improves motor function. - Immune thrombocytopenia (ITP): raises platelet counts and reduces bleeding risk. - Multifactorial autoimmune disorders: provides immunomodulatory effects that can lessen disease activity.

Adverse reactions to Octagam vary in frequency and severity.

Common Side Effects: - Headache - Fever - Chills - Nausea - Fatigue - Mild infusion‑site reactions

Serious or Rare Side Effects: - Anaphylaxis - Acute hemolytic anemia - Thromboembolic events - Renal impairment - Aseptic meningitis - Severe thrombocytopenia

Octagam should be administered under medical supervision with attention to patient history and monitoring.

- Assess renal function: adjust infusion rate in patients with renal impairment. - Screen for IgA deficiency: consider risk of anti‑IgA antibodies. - Monitor for thrombotic risk: evaluate history of clotting disorders. - Observe for signs of infection: patients with active infections may need treatment before infusion. - Review concomitant anticoagulant therapy: adjust dosing if necessary. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Octagam may interact with several drug classes, requiring clinical awareness.

Major Interactions (Avoid): - Live vaccines: risk of reduced vaccine efficacy and increased infection. - High‑dose aspirin or NSAIDs: heightened risk of bleeding during infusion.

Moderate Interactions (Monitor Closely): - Anticoagulants (e.g., warfarin): may increase bleeding tendency; monitor INR. - Immunosuppressants (e.g., rituximab): may alter immune response; adjust monitoring. - Diuretics: potential for fluid overload; assess volume status. - ACE inhibitors: rare reports of angio‑edema; observe for swelling. - Monoclonal antibodies targeting B‑cells: may affect therapeutic outcomes.